Cargando…

Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection

BACKGROUND: Earlier kinetics of serum HCV core antigen (HCVcAg) and its predictive value on sustained virological response (SVR) were investigated in patients with genotype 1 HCV infection during antiviral treatment. METHODS: In a multi-centered, randomized and positive drug-controlled phase IIb cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Bo, Yang, Rui-Feng, Xie, Qing, Shang, Jia, Kong, Fan-Yun, Zhang, Hai-Ying, Rao, Hui-Ying, Jin, Qian, Cong, Xu, Liu, Yun-Ye, Kang, Yi, Wei, Lai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995626/ https://www.ncbi.nlm.nih.gov/pubmed/24625322 http://dx.doi.org/10.1186/1471-230X-14-47

Ejemplares similares

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Early predictive efficacy of core antigen on antiviral outcomes in genotype 1 hepatitis C virus infected patients
por: Feng, Bo, et al.
Publicado: (2015)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV
por: Odolini, Silvia, et al.
Publicado: (2014)

Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan
por: Yousaf, Muhammad Z, et al.
Publicado: (2011)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
por: Pellicelli, Adriano M, et al.
Publicado: (2012)

Is HCV core antigen a reliable marker of viral load? An evaluation of HCV core antigen automated immunoassay
por: Hadziyannis, Emilia, et al.
Publicado: (2013)

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
por: Smit, Colette, et al.
Publicado: (2015)

Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials
por: Struble, Kimberly, et al.
Publicado: (2019)

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
por: Labarga, P, et al.
Publicado: (2010)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
por: Wang, Yuhan, et al.
Publicado: (2021)

IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C
por: Estrabaud, Emilie, et al.
Publicado: (2015)

Predictors of sustained virologic response in hepatitis C genotype 4: beyond the usual suspects
por: Abdo, Ayman A., et al.
Publicado: (2009)

Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2016)

Cryptococcal Antigen Screening and Missed Opportunities for Earlier Diagnosis Among People With HIV and Poor Virologic Control in the Bronx, NY
por: Yoon, Hyunah, et al.
Publicado: (2022)

CD127 Expression, Exhaustion Status and Antigen Specific Proliferation Predict Sustained Virologic Response to IFN in HCV/HIV Co-Infected Individuals
por: Kared, Hassen, et al.
Publicado: (2014)

Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2013)

Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response
por: Khattab, Mahmoud A., et al.
Publicado: (2022)

Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3
por: Niederau, Claus, et al.
Publicado: (2014)

High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world setting
por: Han, Qunying, et al.
Publicado: (2019)

Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality
por: Wang, Yijin, et al.
Publicado: (2019)

Virologic Tools for HCV Drug Resistance Testing
por: Fourati, Slim, et al.
Publicado: (2015)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2
por: Han, Sung Yong, et al.
Publicado: (2021)

HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b
por: Fan, Zhijuan, et al.
Publicado: (2019)

Low-Cost Predictors for Liver Function and Clinical Outcomes after Sustained Virological Response in Patients with HCV-Related Cirrhosis and Thrombocytopenia
por: Omer, Secil, et al.
Publicado: (2023)

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
por: Orr, Cody, et al.
Publicado: (2020)

Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis
por: Radhakrishnan, Kavita, et al.
Publicado: (2019)

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
por: Hamdane, Nourdine, et al.
Publicado: (2019)

Frequency and predictive factors of minimal hepatic encephalopathy before and after sustained virological response in HCV cirrhosis
por: Piedade, Juliana, et al.
Publicado: (2022)

Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections
por: Manickam, Cordelia, et al.
Publicado: (2014)

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
por: Marascio, Nadia, et al.
Publicado: (2019)

Earlier adolescent substance use onset predicts stronger connectivity between reward and cognitive control brain networks
por: Weissman, David G., et al.
Publicado: (2015)

Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success
por: Greninger, Alexander L
Publicado: (2021)

Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia
por: Chuaypen, Natthaya, et al.
Publicado: (2022)

A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin
por: Asselah, Tarik, et al.
Publicado: (2016)

Hepatitis C diagnosics: clinical evaluation of the HCV-core antigen determination
por: van Helden, Josef
Publicado: (2014)

Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients
por: Wagner, Glenn, et al.
Publicado: (2011)

Analysis of the Virus Dynamics Model Reveals That Early Treatment of HCV Infection May Lead to the Sustained Virological Response
por: Gupta, Saurabh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j36n0qqbsp9uba405sguktge0a